LRG1 promotes atherosclerosis by inducing macrophage M1-like polarization
Proceedings of the National Academy of Sciences · 27.08.2024 · 121 (35)
DOI: 10.1073/pnas.2405845121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 23.08.2024. Verfasst von Juan Wang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Heart-Center of Beijing Chao-Yang hospital, Capital Medical University, Beijing Key Laboratory of Hypertension, Beijing 100020, China. Hauptthemen laut MEDLINE: Atherosclerosis, Macrophages, Glycoproteins. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: national Natural science Fund.
Abstract (Originalsprache)
Atherosclerosis is a chronic inflammatory disease of the arterial wall characterized by the accumulation of cholesterol-rich lipoproteins in macrophages. How macrophages commit to proinflammatory polarization under atherosclerosis conditions is not clear. Report here that the level of a circulating protein, leucine-rich alpha-2 glycoprotein 1 (LRG1), is elevated in the atherosclerotic tissue and serum samples from patients with coronary artery disease (CAD). LRG1 stimulated macrophages to proinflammatory M1-like polarization through the activation of extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways. The LRG1 knockout mice showed significantly delayed atherogenesis progression and reduced levels of macrophage-related proinflammatory cytokines in a high-fat diet–induced Apoe −/− mouse atherosclerosis model. An anti-LRG1 neutralizing antibody also effectively blocked LRG1-induced macrophage M1-like polarization in vitro and conferred therapeutic benefits to animals with ApoE deficiency-induced atherosclerosis. LRG1 may therefore serve as an additional biomarker for CAD and targeting LRG1 could offer a potential therapeutic strategy for CAD patients by mitigating the proinflammatory response of macrophages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Heart-Center of Beijing Chao-Yang hospital, Capital Medical University, Beijing Key Laboratory of Hypertension, Beijing 100020, China.
- National Institute of Biological Sciences, Beijing 102206, China.
- Department of Cardiology, The Second Medical Center, Beijing 301 Hospital, Beijing 100853, China.
- Tsinghua Institute of Multidisciplinary Biomedical Research, Tsinghua University, Beijing 102206, China.
ORCID-Profile: Juan Wang, Jing Wang, Jiuchang Zhong, Ze Zhang, Zhizhong Wei, Jia Guo, Sitao Zhang, Xiaodong Wang
Förderung
- national Natural science Fund
Zitieren
APA
Wang, J., Wang, J., Zhong, J., Liu, H., Li, W., Chen, M., Xu, L., Zhang, W., Zhang, Z., Wei, Z., Guo, J., Wang, X., Sui, J., Liu, X., Zhang, S., & Wang, X. (2024). LRG1 promotes atherosclerosis by inducing macrophage M1-like polarization. Proceedings of the National Academy of Sciences, 121(35). https://doi.org/10.1073/pnas.2405845121
Vancouver
Wang J, Wang J, Zhong J, Liu H, Li W, Chen M, et al. LRG1 promotes atherosclerosis by inducing macrophage M1-like polarization. Proceedings of the National Academy of Sciences. 2024;121(35). doi:10.1073/pnas.2405845121
BibTeX
@article{Wang2024,
author = {Wang, Juan and Wang, Jing and Zhong, Jiuchang and Liu, Hongbin and Li, Weiming and Chen, Mulei and Xu, Li and Zhang, Wenbin and Zhang, Ze and Wei, Zhizhong and Guo, Jia and Wang, Xinyu and Sui, Jianhua and Liu, Xingpeng and Zhang, Sitao and Wang, Xiaodong},
title = {LRG1 promotes atherosclerosis by inducing macrophage M1-like polarization},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {35},
doi = {10.1073/pnas.2405845121}
}
EUVIMED